USP15 and chronic myelogenous leukemia, BCR-ABL1 positive: Also, because USP15 is highly expressed in primary blood–derived tumors, chronic myeloid leukemia (CML) and acute myeloid leukemia (AML) patients, it can serve as a target for cancer therapy.